The abstract of the paper "Growth retardation in children with kidney disease" is corrected as follows. Chronic kidney disease (CKD) and end stage renal disease (ESRD) are usually associated with growth failure. The pathogenesis of growth delay in CKD is influenced by the degree of renal dysfunction and the presence of metabolic acidosis, protein calorie malnutrition, disorders of water and electrolyte metabolism, metabolic bone disease, anemia, and alterations in gonadotropic and somatothrophic axis but also comorbidities, factors associated with the treatment modality, and the genetic growth potential determined by midparental height. This review covers the current knowledge to optimize all aspects of treatment, including correction of metabolic disorders and appropriate use of hormone therapy.
